Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and lo... by Niethammer Andreas G, Lubenau Heinz, Mikus Gerd, Knebel Philipp, Hohmann Nicolas, Leowardi Christine, Beckhove Philipp, Akhisaroglu Mustafa, Ge Yingzi, Springer Marco, Grenacher Lars, Buchler Markus W, Koch Moritz, Weitz Jürgen, Haefeli Walter E, Schmitz-Winnenthal Friedrich H

Get full text